|
Development of a Pharmacodynamic Marker of EWS-FLI1 Activity to Aid in the Clinical Translation of Targeted Therapies for Ewing sarcoma |
Van Andel Research Institute |
I Care I Cure |
|
Children's Hospital Colorado Experimental Therapeutics Program |
Children’s Hospital Colorado |
Northwestern Mutual Foundation |
|
Reactivating Apoptosis in Refractory Pediatric Cancer by Molecular Inhibition of MCL-1 |
Dana-Farber Cancer Institute |
Cure4Cam Childhood Cancer Foundation |
|
The Phase I/II Trials Collaborative for Children, Adolescents, and Young Adults at UH Rainbow Babies & Children's Hospital and the Case Comprehensive Cancer Center |
Case Western Reserve University |
Flashes of Hope |
|
Novel Therapeutic Targets in Relapse T-cell Acute Lymphoblastic Leukemia
|
Massachusetts General Hospital |
Cure4Cam Childhood Cancer Foundation |
|
Nationwide Children's Hospital Phase I/II Infrastructure |
Research Institute at Nationwide Children's Hospital |
Flashes of Hope |
|
Nanoparticle Delivery of Therapeutic Agents in Neuroblastomas |
Children’s Hospital of Philadelphia |
Cure4Cam Childhood Cancer Foundation |
|
The Role of PTPRD as a Tumor Suppressor in Neuroblastoma Pathogenesis |
Mayo Clinic |
Northwestern Mutual Foundation |
|
The Regulation of Hematopoietic Stem Cell Function by Granulocyte-Colony Stimulating Factor |
Washington University |
Northwestern Mutual Foundation |
|
Multifunctional Nanomaterials for the Prevention of Radiotherapy's Side Effects and Childhood Cancers |
Massachusetts General Hospital |
Northwestern Mutual Foundation |
